J Med Microbiol 2010,59(Pt Epacadostat 6):708–712.PubMedCrossRef 12. Safa A, Nair GB, Kong RY: Evolution of new variants of Vibrio cholerae O1. Trends Microbiol 2010,18(1):46–54.PubMedCrossRef 13. De SN: Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature 1959,183(4674):1533–1534.PubMedCrossRef

14. Waldor MK, Citarinostat mw Mekalanos JJ: Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996,272(5270):1910–1914.PubMedCrossRef 15. Galen JE, Ketley JM, Fasano A, Richardson SH, Wasserman SS, Kaper JB: Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun 1992,60(2):406–415.PubMed 16. Jermyn WS, Boyd EF: Molecular evolution of Vibrio pathogenicity selleck chemicals llc island-2 (VPI-2): mosaic structure among Vibrio cholerae and Vibrio mimicus natural isolates. Microbiology 2005,151(Pt 1):311–322.PubMedCrossRef 17. Dziejman M, Balon E, Boyd D, Fraser CM, Heidelberg JF, Mekalanos JJ: Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad

Sci USA 2002,99(3):1556–1561.PubMedCrossRef 18. Jermyn WS, Boyd EF: Characterization of a novel Vibrio pathogenicity island (VPI-2) encoding neuraminidase (nanH) among toxigenic Vibrio cholerae isolates. Microbiology 2002,148(Pt 11):3681–3693.PubMed 19. Almagro-Moreno S, Boyd EF: Sialic Acid Catabolism Confers a Competitive Advantage to Pathogenic Vibrio cholerae in the Mouse Intestine. Infect Immun 2009,77(9):3807–3816.PubMedCrossRef 20. Almagro-Moreno S, Boyd EF: Insights into the evolution of sialic acid catabolism among bacteria. BMC Evol Biol 2009,9(1):118.PubMedCrossRef 21. Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, Rahman MH, Heidelberg JF, Decker J, Li L, et al.: Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci USA 2005,102(9):3465–3470.PubMedCrossRef 22. Chen Y, Johnson JA, Pusch GD, Morris JG Jr, Stine OC: The genome of non-O1 Vibrio cholerae NRT36 S demonstrates the presence of pathogenic mechanisms that are distinct from those of O1 Vibrio cholerae.

Infect Immun 2007,75(5):2645–2647.PubMedCrossRef 23. Murphy RA, Boyd EF: Three pathogenicity islands of Vibrio cholerae can PRKD3 excise from the chromosome and form circular intermediates. J Bacteriol 2008,190(2):636–647.PubMedCrossRef 24. Alam A, Tam V, Hamilton E, Dziejman M: vttRA and vttRB Encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/non-O139 Vibrio cholerae strain. Infect Immun 2010,78(6):2554–2570.PubMedCrossRef 25. Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ: A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 2007,1(2):95–107.PubMedCrossRef 26.